Mainz Biomed N.V. (MYNZ)

Mainz Biomed Statistics

Total Valuation

Mainz Biomed has a market cap or net worth of $5.33 million. The enterprise value is $6.51 million.

Market Cap	5.33M
Enterprise Value	6.51M

Important Dates

The next estimated earnings date is Tuesday, October 21, 2025, before market open.

Earnings Date	Oct 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Mainz Biomed has 3.44 million shares outstanding. The number of shares has increased by 138.45% in one year.

Current Share Class	3.44M
Shares Outstanding	3.44M
Shares Change (YoY)	+138.45%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.49%
Owned by Institutions (%)	3.61%
Float	2.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.31
Forward PS	n/a
PB Ratio	1.93
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	9.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.52, with a Debt / Equity ratio of 1.23.

Current Ratio	0.52
Quick Ratio	0.35
Debt / Equity	1.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-26.47

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-114.35%
Return on Invested Capital (ROIC)	-214.19%
Return on Capital Employed (ROCE)	-437.77%
Revenue Per Employee	$25,382
Profits Per Employee	-$729,658
Employee Count	26
Asset Turnover	0.07
Inventory Turnover	0.42

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.93% in the last 52 weeks. The beta is 0.26, so Mainz Biomed's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	-80.93%
50-Day Moving Average	1.69
200-Day Moving Average	3.26
Relative Strength Index (RSI)	41.23
Average Volume (20 Days)	56,189

Short Selling Information

The latest short interest is 101,950, so 2.96% of the outstanding shares have been sold short.

Short Interest	101,950
Short Previous Month	107,648
Short % of Shares Out	2.96%
Short % of Float	3.82%
Short Ratio (days to cover)	1.38

Income Statement

In the last 12 months, Mainz Biomed had revenue of $659,935 and -$18.97 million in losses. Loss per share was -$8.39.

Revenue	659,935
Gross Profit	445,434
Operating Income	-16.70M
Pretax Income	-18.97M
Net Income	-18.97M
EBITDA	-15.99M
EBIT	-16.70M
Loss Per Share	-$8.39

Balance Sheet

The company has $1.91 million in cash and $3.09 million in debt, giving a net cash position of -$1.18 million or -$0.34 per share.

Cash & Cash Equivalents	1.91M
Total Debt	3.09M
Net Cash	-1.18M
Net Cash Per Share	-$0.34
Equity (Book Value)	2.52M
Book Value Per Share	0.80
Working Capital	-2.90M

Cash Flow

In the last 12 months, operating cash flow was -$15.46 million and capital expenditures $14,588, giving a free cash flow of -$17.19 million.

Operating Cash Flow	-15.46M
Capital Expenditures	14,588
Free Cash Flow	-17.19M
FCF Per Share	-$5.00

Margins

Gross Margin	67.50%
Operating Margin	-2,530.90%
Pretax Margin	-2,874.69%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mainz Biomed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-138.45%
Shareholder Yield	-138.45%
Earnings Yield	-355.81%
FCF Yield	-322.50%

Analyst Forecast

The average price target for Mainz Biomed is $14.00, which is 803.23% higher than the current price. The consensus rating is "Buy".

Price Target	$14.00
Price Target Difference	803.23%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	143.03%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 3, 2024. It was a reverse split with a ratio of 1:40.

Last Split Date	Dec 3, 2024
Split Type	Reverse
Split Ratio	1:40

Scores

Altman Z-Score	n/a
Piotroski F-Score	3